ResearcherCleveland ClinicNo recent work listed
Namita Sharma Gandhi
Matched on ORCID iD 0000-0002-6456-9453; OpenAlex author ID A5015990700. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2016: 1 paper · 2017: none · 2018: 2 papers · 2019: none · 2020: 1 paper · 2021: 1 paper
Papers 5
- Efficacy of Perioperative Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Phase 2 Randomized Clinical Trial. Co-author DOI 10.1001/jamaoncol.2020.7328↗
- Surgical Outcome Results From SWOG S1505: A Randomized Clinical Trial of mFOLFIRINOX Versus Gemcitabine/Nab-paclitaxel for Perioperative Treatment of Resectabl… Co-author DOI 10.1097/sla.0000000000004155↗
- Imaging mimics of pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00261-017-1330-1↗
- Gastroenterology and pancreatic adenocarcinoma: what the radiologist needs to know. First author DOI 10.1007/s00261-017-1347-5↗
- Imaging Evaluation of Pancreatic Cancer. First author DOI 10.1016/j.suc.2016.07.007↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Myra Feldman · 2 shared papers, 2016–2018 · strength 0.24
- Davendra P. S. Sohal · 2 shared papers, 2020–2021 · strength 0.22
- Paper Efficacy of Perioperative Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Phase 2 Randomized Clinical Trial. DOI 10.1001/jamaoncol.2020.7328↗
- Paper Surgical Outcome Results From SWOG S1505: A Randomized Clinical Trial of mFOLFIRINOX Versus Gemcitabine/Nab-paclitaxel … DOI 10.1097/sla.0000000000004155↗
- Muhammad Shaalan Beg · 2 shared papers, 2020–2021 · strength 0.22
- Paper Efficacy of Perioperative Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Phase 2 Randomized Clinical Trial. DOI 10.1001/jamaoncol.2020.7328↗
- Paper Surgical Outcome Results From SWOG S1505: A Randomized Clinical Trial of mFOLFIRINOX Versus Gemcitabine/Nab-paclitaxel … DOI 10.1097/sla.0000000000004155↗
- Andrew M. Lowy · 2 shared papers, 2020–2021 · strength 0.22
- Paper Efficacy of Perioperative Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Phase 2 Randomized Clinical Trial. DOI 10.1001/jamaoncol.2020.7328↗
- Paper Surgical Outcome Results From SWOG S1505: A Randomized Clinical Trial of mFOLFIRINOX Versus Gemcitabine/Nab-paclitaxel … DOI 10.1097/sla.0000000000004155↗
- Andrea Wang‐Gillam · 2 shared papers, 2020–2021 · strength 0.22
- Paper Efficacy of Perioperative Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Phase 2 Randomized Clinical Trial. DOI 10.1001/jamaoncol.2020.7328↗
- Paper Surgical Outcome Results From SWOG S1505: A Randomized Clinical Trial of mFOLFIRINOX Versus Gemcitabine/Nab-paclitaxel … DOI 10.1097/sla.0000000000004155↗
- Philip A. Philip · 2 shared papers, 2020–2021 · strength 0.22
- Paper Efficacy of Perioperative Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Phase 2 Randomized Clinical Trial. DOI 10.1001/jamaoncol.2020.7328↗
- Paper Surgical Outcome Results From SWOG S1505: A Randomized Clinical Trial of mFOLFIRINOX Versus Gemcitabine/Nab-paclitaxel … DOI 10.1097/sla.0000000000004155↗
- Elena Gabriela Chiorean · 2 shared papers, 2020–2021 · strength 0.22
- Paper Efficacy of Perioperative Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Phase 2 Randomized Clinical Trial. DOI 10.1001/jamaoncol.2020.7328↗
- Paper Surgical Outcome Results From SWOG S1505: A Randomized Clinical Trial of mFOLFIRINOX Versus Gemcitabine/Nab-paclitaxel … DOI 10.1097/sla.0000000000004155↗
- Howard S. Höchster · 2 shared papers, 2020–2021 · strength 0.22
- Paper Efficacy of Perioperative Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Phase 2 Randomized Clinical Trial. DOI 10.1001/jamaoncol.2020.7328↗
- Paper Surgical Outcome Results From SWOG S1505: A Randomized Clinical Trial of mFOLFIRINOX Versus Gemcitabine/Nab-paclitaxel … DOI 10.1097/sla.0000000000004155↗
- Syed Ameen Ahmad · 1 shared paper, 2021 · strength 0.12
- Ott Le · 1 shared paper, 2018 · strength 0.12
- Abhik Bhattacharya · 1 shared paper, 2018 · strength 0.12
- Prabhleen Chahal · 1 shared paper, 2018 · strength 0.12
- Gareth J Morris‐Stiff · 1 shared paper, 2018 · strength 0.12
- Syed Arif Ahmad · 1 shared paper, 2020 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.